麗人麗粧(605136.SH):2020年度計提資產減值準備約1億元
格隆匯 3 月 17日丨麗人麗粧(605136.SH)公佈,公司於2021 年3月16日以現場結合通訊會議方式召開公司第二屆董事會第十六次會議,會議審議通過《關於2020年度計提資產減值準備的議案》。該議案尚需提交股東大會審議。
為客觀、公允反映資產狀況,本着謹慎性原則,公司依照《企業會計準則》和公司相關會計政策,對2020年末存貨、其他應收款、應收賬款等資產進行了全面減值測試,對可能發生減值損失的部分資產計提減值準備人民幣合計10020.11萬元,其中應收賬款計提人民幣6.75萬元,其他應收款計提人民幣1376.47萬元,存貨跌價損失計提人民幣8636.89萬元。
此次計提資產減值準備後,減少了公司2020年度利潤總額人民幣10020.11萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.